Drug Shortage Report for MYLAN-CLONAZEPAM
Report ID | 31518 |
Drug Identification Number | 02230950 |
Brand name | MYLAN-CLONAZEPAM |
Common or Proper name | CLONAZEPAM |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CLONAZEPAM |
Strength(s) | 0.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100BT, 500BT |
ATC code | N03AE |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-12-01 |
Actual start date | |
Estimated end date | |
Actual end date | 2017-12-01 |
Shortage status | Resolved |
Updated date | 2017-12-02 |
Company comments | discontinued under ID 30312 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2017-12-02 | English | Compare |
v2 | 2017-12-01 | French | Compare |
v1 | 2017-12-01 | English | Compare |
Showing 1 to 3 of 3